Oragenics (OGEN) Other Working Capital Changes (2022 - 2024)
Oragenics' (OGEN) quarterly Other Working Capital Changes came in at -$9811.0 in Q1 2024, up 80.47% YoY from -$5436.3 in Q2 2023, and up 80.47% on a QoQ basis from -$50237.0 in Q1 2023.
Oragenics (OGEN) Other Working Capital Changes (2022 - 2024) Analysis & Trends
Oragenics (OGEN) has 3 years of Other Working Capital Changes data on file, last reported at -$9811.0 in Q1 2024.
- Quarterly Other Working Capital Changes rose 80.47% year-over-year to -$9811.0 in Q1 2024, while the trailing twelve-month figure through Dec 2024 was -$9811.0 (changed N/A YoY) and the FY2024 annual result came in at -$9811.0, up 97.17% from the prior year.
- Other Working Capital Changes improved to -$9811.0 in Q1 2024, from -$50237.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.3 million in Q1 2022 to a low of -$1.5 million in Q4 2024.
- A 5-year average of -$52977.1 and a median of -$100878.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes decreased 6.15% — and 2024, when it surged 80.47%.
- Tracing OGEN's Other Working Capital Changes over 3 years: stood at -$47327.0 in 2022, then retreated by 6.15% to -$50237.0 in 2023, then surged by 80.47% to -$9811.0 in 2024.
- The last three Other Working Capital Changes figures came in at -$9811.0 (Q1 2024), -$50237.0 (Q1 2023), and -$47327.0 (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -9,811.00 |
| Mar 31, 2024 | -9,811.00 |
| Mar 31, 2024 | -9,811.00 |
| Mar 31, 2023 | -50,237.00 |
| Mar 31, 2023 | -50,237.00 |
| Mar 31, 2023 | -50,237.00 |
| Mar 31, 2022 | -47,327.00 |
| Mar 31, 2022 | -47,327.00 |
| Mar 31, 2022 | -47,327.00 |